Clinical Trial Update: A Study to Evaluate the Efficacy and Safety of Roxadustat for the Treatment of Anemia in Participants Receiving Chemotherapy Treatment for Non-Myeloid Malignancies [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating the efficacy and safety of Roxadustat for anemia in patients receiving chemotherapy for non-myeloid malignancies has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chemotherapy-induced Anemia
• Non-myeloid Malignancies Anemia

Drugs mentioned

• Roxadustat (roxadustat)

Snippet

Sponsor: Kyntra Bio | Conditions: Chemotherapy Induced Anemia | Phase 3 | Status: COMPLETED